Correlation Between YuantaP Shares and OBI Pharma
Can any of the company-specific risk be diversified away by investing in both YuantaP Shares and OBI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YuantaP Shares and OBI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YuantaP shares Taiwan Top and OBI Pharma, you can compare the effects of market volatilities on YuantaP Shares and OBI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YuantaP Shares with a short position of OBI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of YuantaP Shares and OBI Pharma.
Diversification Opportunities for YuantaP Shares and OBI Pharma
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between YuantaP and OBI is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding YuantaP shares Taiwan Top and OBI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OBI Pharma and YuantaP Shares is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YuantaP shares Taiwan Top are associated (or correlated) with OBI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OBI Pharma has no effect on the direction of YuantaP Shares i.e., YuantaP Shares and OBI Pharma go up and down completely randomly.
Pair Corralation between YuantaP Shares and OBI Pharma
Assuming the 90 days trading horizon YuantaP shares Taiwan Top is expected to generate 0.57 times more return on investment than OBI Pharma. However, YuantaP shares Taiwan Top is 1.74 times less risky than OBI Pharma. It trades about 0.12 of its potential returns per unit of risk. OBI Pharma is currently generating about -0.16 per unit of risk. If you would invest 17,840 in YuantaP shares Taiwan Top on September 13, 2024 and sell it today you would earn a total of 1,450 from holding YuantaP shares Taiwan Top or generate 8.13% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 95.16% |
Values | Daily Returns |
YuantaP shares Taiwan Top vs. OBI Pharma
Performance |
Timeline |
YuantaP shares Taiwan |
OBI Pharma |
YuantaP Shares and OBI Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with YuantaP Shares and OBI Pharma
The main advantage of trading using opposite YuantaP Shares and OBI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YuantaP Shares position performs unexpectedly, OBI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will offset losses from the drop in OBI Pharma's long position.YuantaP Shares vs. YuantaP shares MSCI Taiwan | YuantaP Shares vs. YuantaP shares Taiwan GreTai | YuantaP Shares vs. YuantaP shares SSE50 | YuantaP Shares vs. YuantaP shares Taiwan Mid Cap |
OBI Pharma vs. TaiMed Biologics | OBI Pharma vs. PharmaEngine | OBI Pharma vs. Medigen Biotechnology | OBI Pharma vs. TTY Biopharm Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |